Dana Albon (D P Albon)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Top Venues

BMJ open quality

Pharmacotherapy

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Pediatric pulmonology

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis. Pharmacotherapy 44 (3) (2024)
Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis. Pharmacotherapy 44 (3) (2024)
Emily Mitchell, Dana Albon
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants. Pediatric pulmonology 59 (7) (2024)
Emily Mitchell, Dana Albon
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants. Pediatric pulmonology (2024)
Ajay Mehta, Irene Lee, Galvin Li, Marieke Jones, Lydia Hanson, Kevin Lonabaugh, Rhonda List, Larry Borish, Dana Albon
The Impact of CFTR Modulator Triple Therapy on Type 2 Inflammatory Response in Patients with Cystic Fibrosis. Research square (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis. Pharmacotherapy (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Rhonda List, George Solomon, Stacy Bichl, Bethany Jablonski Horton, Shiyi Shen, Bean Corcoran, Hossein Sadeghi, Maria T Britto, Clement Ren, Dana Albon, null null
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative. BMJ open quality 12 (4) (2023)
Dana Albon, Lijia Zhang, James Patrie, Marieke Jones, Z Galvin Li, Emily Noonan, Larry Borish
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19 (1) (2023)
Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon
Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis. Pharmacotherapy (2023)
A M Mehta, I Lee, G Li, M K Jones, L Hanson, K Lonabaugh, R List, L Borish, Dana Albon
The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19 (1) (2023)
Dana Albon, Lijia Zhang, James Patrie, Marieke Jones, Z Galvin Li, Emily Noonan, Larry Borish
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19 (1) (2023)
Dana Albon, Lacrecia Thomas, Lindsay Hoberg, Sophia Stamper, Lindsay Somerville, Prigi Varghese, Ella Balasa, Matthew Roman, Maria T Britto, Melanie Miner, Emily Gehring, Clifford Gammon, Raouf S Amin, Michael Seid, Mike Powers, null null
Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting. BMJ open quality 11 (2) (2022)
Deirdre Jennings, Rhonda List, Heather M Bruschwein, Martina Compton, Lindsay Somerville, Lauren Williamson, Rachel Murray, Brielle Evangelista, Dana Albon
Social determinants of health screening and intervention: A cystic fibrosis quality improvement process. Pediatric pulmonology 57 (12) (2022)
Heather M Bruschwein, Morgan Soper, Deirdre Jennings, Lindsay Somerville, Rhonda List, Martina H Compton, Rachel Turner, Dana Albon
Mental health screening of patients with cystic fibrosis through telehealth during COVID-19: Evaluation of feasibility and process adoption. Families, systems & health : the journal of collaborative family healthcare 40 (3) (2022)
Martina Compton, Rhonda List, Elissa Starheim, Lindsay Somerville, Lauren Williamson, Rachel Murray, Deirdre Jennings, Heather Bruschwein, Dana Albon
Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process. BMJ open quality 10 (3) (2021)
Lijia Zhang, Larry Borish, Anna Smith, Lindsay Somerville, Dana Albon
Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 16 (2020)